Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for PDEX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 74.98M
December 31, 2025 62.26M
September 30, 2025 64.30M
June 30, 2025 63.21M
March 31, 2025 64.27M
December 31, 2024 60.37M
September 30, 2024 54.31M
June 30, 2024 54.21M
March 31, 2024 50.55M
December 31, 2023 51.43M
September 30, 2023 49.58M
June 30, 2023 54.83M
March 31, 2023 46.98M
December 31, 2022 47.58M
September 30, 2022 47.96M
June 30, 2022 51.22M
March 31, 2022 43.88M
December 31, 2021 42.11M
September 30, 2021 41.86M
June 30, 2021 41.68M
March 31, 2021 40.32M
December 31, 2020 38.37M
September 30, 2020 30.80M
June 30, 2020 31.75M
March 31, 2020 28.23M
Date Value
December 31, 2019 28.73M
September 30, 2019 27.97M
June 30, 2019 26.13M
March 31, 2019 25.63M
December 31, 2018 24.03M
September 30, 2018 25.19M
June 30, 2018 20.39M
March 31, 2018 19.48M
December 31, 2017 18.81M
September 30, 2017 18.17M
June 30, 2017 17.11M
March 31, 2017 15.39M
December 31, 2016 15.03M
September 30, 2016 11.93M
June 30, 2016 11.41M
March 31, 2016 11.52M
December 31, 2015 12.17M
September 30, 2015 12.27M
June 30, 2015 12.52M
March 31, 2015 12.62M
December 31, 2014 11.94M
September 30, 2014 11.54M
June 30, 2014 11.71M
March 31, 2014 10.19M
December 31, 2013 10.39M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 109.22B
AngioDynamics, Inc. 267.16M
Alphatec Holdings, Inc. 791.03M
AtriCure, Inc. 676.64M
Baxter International, Inc. 19.79B

Total Assets (Quarterly) Related Metrics